Free Trial

Hitesh Ramani Sells 12,500 Shares of UiPath Inc. (NYSE:PATH) Stock

UiPath logo with Business Services background
Remove Ads

UiPath Inc. (NYSE:PATH - Get Free Report) CAO Hitesh Ramani sold 12,500 shares of the firm's stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $10.19, for a total transaction of $127,375.00. Following the transaction, the chief accounting officer now directly owns 314,891 shares of the company's stock, valued at approximately $3,208,739.29. This represents a 3.82 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

UiPath Stock Up 2.4 %

PATH stock traded up $0.26 during trading on Friday, reaching $10.89. 18,592,011 shares of the company's stock were exchanged, compared to its average volume of 10,253,219. The firm has a market cap of $6.00 billion, a PE ratio of -68.03 and a beta of 1.04. The company's fifty day moving average price is $12.03 and its 200-day moving average price is $12.87. UiPath Inc. has a 1-year low of $9.38 and a 1-year high of $21.17.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Norges Bank bought a new stake in shares of UiPath during the 4th quarter worth $71,191,000. Senvest Management LLC boosted its position in shares of UiPath by 29.2% in the 4th quarter. Senvest Management LLC now owns 14,074,783 shares of the company's stock valued at $178,890,000 after purchasing an additional 3,180,300 shares during the period. AQR Capital Management LLC raised its holdings in shares of UiPath by 45.3% during the fourth quarter. AQR Capital Management LLC now owns 6,646,320 shares of the company's stock valued at $84,209,000 after acquiring an additional 2,072,089 shares during the period. Jacobs Levy Equity Management Inc. lifted its holdings in shares of UiPath by 35.6% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 5,459,071 shares of the company's stock valued at $69,385,000 after purchasing an additional 1,432,569 shares in the last quarter. Finally, Marshall Wace LLP boosted its position in UiPath by 111.8% during the 4th quarter. Marshall Wace LLP now owns 2,456,102 shares of the company's stock worth $31,217,000 after acquiring an additional 1,296,382 shares during the period. 62.50% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analyst Weigh In

A number of equities analysts recently commented on PATH shares. Bank of America reiterated an "underperform" rating and issued a $10.00 price target (down from $18.00) on shares of UiPath in a research note on Thursday, March 13th. Mizuho lowered their price target on UiPath from $14.00 to $12.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. UBS Group reduced their price objective on UiPath from $14.00 to $10.00 and set a "sell" rating on the stock in a research note on Thursday, March 13th. Canaccord Genuity Group lowered their target price on shares of UiPath from $19.00 to $14.00 and set a "buy" rating for the company in a research note on Thursday, March 13th. Finally, Morgan Stanley reduced their price target on shares of UiPath from $16.00 to $12.00 and set an "equal weight" rating on the stock in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $12.78.

Get Our Latest Stock Report on UiPath

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Stories

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads